Metabolic Acidosis 1 Year Following Kidney Transplantation and Subsequent Cardiovascular Events and Mortality: An Observational Cohort Study.


Journal

American journal of kidney diseases : the official journal of the National Kidney Foundation
ISSN: 1523-6838
Titre abrégé: Am J Kidney Dis
Pays: United States
ID NLM: 8110075

Informations de publication

Date de publication:
04 2019
Historique:
received: 19 04 2018
accepted: 02 12 2018
pubmed: 2 2 2019
medline: 1 2 2020
entrez: 2 2 2019
Statut: ppublish

Résumé

Recent studies suggest that metabolic acidosis is associated with mortality and graft failure in kidney transplant recipients. However, it is unknown whether serum bicarbonate (measured as total carbon dioxide [tCO Observational cohort study. Single-center study of 2,128 kidney transplant recipients free of CVEs during the first 13.5 months following transplantation. tCO Ischemic, arrhythmic, and heart failure CVEs and death from any cause. Independent associations were assessed using multivariable proportional hazards regression models. Restricted cubic spline Poisson models were used to explore nonlinear associations. Linear spline proportional hazards models were used to assess associations at different tCO The prevalence of metabolic acidosis defined as tCO Single-center observational study. Metabolic acidosis is an independent risk factor for ischemic CVEs after kidney transplantation. It is unknown whether correction of acidosis improves outcomes in these patients.

Identifiants

pubmed: 30704880
pii: S0272-6386(19)30002-2
doi: 10.1053/j.ajkd.2018.12.023
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

476-485

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Auteurs

Arjang Djamali (A)

Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI; Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI. Electronic address: axd@medicine.wisc.edu.

Tripti Singh (T)

Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI.

Michal L Melamed (ML)

Department of Medicine, Albert Einstein College of Medicine, Bronx, NY; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY.

James H Stein (JH)

Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI.

Fahad Aziz (F)

Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI.

Sandesh Parajuli (S)

Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI.

Maha Mohamed (M)

Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI.

Neetika Garg (N)

Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI.

Didier Mandelbrot (D)

Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI.

Donald E Wesson (DE)

Baylor Scott and White Health and Wellness Center of BSW Health, Dallas, TX.

Brad C Astor (BC)

Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI; Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH